-
WES of clonally related neuroblastoma and teratoma
Study
EGAS00001005116
-
Cell-free DNA TAPS for early cancer detection
Study
EGAS00001004962
-
Whole genome sequence and RNA-seq data from paired tumour and germline samples from mesothelioma patients.
Study
EGAS00001005196
-
The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival
Study
EGAS00001005201
-
Dissecting the Spatial Heterogeneity of Single Circulating Tumor Cells in Hepatocellular Carcinoma
Study
EGAS00001005204
-
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
Study
EGAS00001005243
-
Longitudinal Single-Cell Profiling Reveals Molecular Heterogeneity and Tumor-Immune Evolution in Refractory Mantle Cell Lymphoma
Study
EGAS00001005019
-
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Study
EGAS00001005023
-
Whole genome sequencing of adult glioblastoma nuclei
Study
EGAS00001005256
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit
Study
EGAS00001005053
-
Transcriptome sequencing of hepatocellular carcinoma biopsies (proteogenomic study)
Study
EGAS00001005074
-
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
Study
EGAS00001005301
-
Anal SCC cell line and parent tumour comparative whole exome sequencing
Study
EGAS00001005077
-
Evolutionary predictability of genetic versus non genetic resistance to anticancer drugs in melanoma
Study
EGAS00001005314
-
Clear cell sarcoma sequencing data
Study
EGAS00001006072
-
Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer
Study
EGAS00001005108
-
Accurate detection and classification of pediatric sarcomas based on cell-free DNA fragmentation patterns
Study
EGAS00001005127
-
Neuroblastoma tumor heterogeneity and cell plasticity (from patients)
Study
EGAS00001005322
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
Paired exome and low-coverage genome sequencing of osteosarcoma
Study
EGAS00001005199
-
Splicing patterns in SF3B1 mutated uveal melanoma generate shared immunogenic tumor-specific neo-epitopes
Study
EGAS00001005226
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Mongolia Western HCC
Study
EGAS00001005364
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
Spatial concordance of DNA methylation classification in diffuse glioma
Study
EGAS00001005434
-
Multimodal single-cell and bulk glioma analyses
Study
EGAS00001005300
-
Gut microbiome sequencing in patients receiving combination immune checkpoint blockade
Study
EGAS00001004885
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
The mutational landscape of primary central nervous system lymphoma (Hipo H050, A050, XD013)
Study
EGAS00001005339
-
46 patients primary malignant glioma cohort in Chinese population
Study
EGAS00001005583
-
Multi-omics of Richter syndrome
Study
EGAS00001005495
-
Evolutionary dynamics of neuroblastoma
Study
EGAS00001004990
-
Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
Study
EGAS00001005437
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__head___neck
Study
EGAS00001005450
-
MM samples for epigenomic translocation of H3K4me3 broad domains following super-enhancer hijacking
Study
EGAS00001005684
-
IMCISION DNAseq
Study
EGAS00001005466
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
Targeted sequencing data and shallow whole genome sequencing data of Follicular lymphoma.
Study
EGAS00001005755
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit - 10x Genomics scRNAseq
Study
EGAS00001005098
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
Efficacy of CDK4/6i in preclinical models of malignant pleural mesothelioma
Study
EGAS00001005352
-
Whole genome and exome sequencing data of invasive micropapillary carcinoma of breast
Study
EGAS00001005902
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257